Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HL 10

Drug Profile

HL 10

Latest Information Update: 15 Jun 2004

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Erasmus University; Friedrich-Alexander-University Erlangen-Nuremberg; HALAS Pharma
  • Developer LEO Pharma
  • Class Phospholipids; Pulmonary surfactants
  • Mechanism of Action Cell membrane permeability enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Acute lung injury

Highest Development Phases

  • Discontinued Acute lung injury; Adult respiratory distress syndrome

Most Recent Events

  • 08 Jun 2004 Discontinued - Phase-III for Acute lung injury in European Union (Intratracheal)
  • 08 Jun 2004 Discontinued - Phase-III for Adult respiratory distress syndrome in European Union (Intratracheal)
  • 13 May 2003 LEO Pharma is seeking a partner for the marketing of HL 10 in the USA and Japan (http://www.leo-pharma.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top